Role of prostaglandin E1 and E2 in the management of neonatal heart disease
- PMID: 645511
Role of prostaglandin E1 and E2 in the management of neonatal heart disease
Similar articles
-
Prostaglandins and the management of congenital heart disease.Am Fam Physician. 1982 Dec;26(6):127-32. Am Fam Physician. 1982. PMID: 6890758
-
Effects of prostaglandins and blockers of prostaglandin synthesis on the ductus arteriosus: animal and human studies.Adv Prostaglandin Thromboxane Res. 1978;4:363-72. Adv Prostaglandin Thromboxane Res. 1978. PMID: 645512 No abstract available.
-
Prostaglandin E1 in neonates with critical congenital heart disease.J Ark Med Soc. 1982 Oct;79(5):167-70. J Ark Med Soc. 1982. PMID: 6183249 No abstract available.
-
Use of prostaglandins in cardiopulmonary diseases of the newborn.Semin Perinatol. 1980 Apr;4(2):135-41. Semin Perinatol. 1980. PMID: 6990504 Review. No abstract available.
-
Cardiovascular therapy in the newborn.Clin Invest Med. 1985;8(4):360-7. Clin Invest Med. 1985. PMID: 3907921 Review.
Cited by
-
Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.Eur J Clin Pharmacol. 1980 Jul;18(1):75-81. doi: 10.1007/BF00561482. Eur J Clin Pharmacol. 1980. PMID: 6995135
-
Variations in local PGE levels: a potential factor in therapeutic responsiveness?Pediatr Cardiol. 1991 Apr;12(2):74-7. doi: 10.1007/BF02238406. Pediatr Cardiol. 1991. PMID: 1866341
-
Platelets contribute to postnatal occlusion of the ductus arteriosus.Nat Med. 2010 Jan;16(1):75-82. doi: 10.1038/nm.2060. Epub 2009 Dec 6. Nat Med. 2010. PMID: 19966813
-
Administration of E-type prostaglandins in ductus-dependent congenital heart disease.Pediatr Cardiol. 1982;2(4):303-5. doi: 10.1007/BF02426977. Pediatr Cardiol. 1982. PMID: 6956847 No abstract available.